Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| AMGN | Amgen Inc. | 0.95% | 171.30 | 1.3% | $495.18m | |
| BIIB | Biogen Inc. | 0.91% | 235.04 | 1.3% | $480.36m | |
| CELG | Celgene Corporation | 0.11% | 96.36 | 1.3% | $457.23m | |
| GILD | Gilead Sciences, Inc. | -0.03% | 66.50 | 0.9% | $434.72m | |
| ILMN | Illumina, Inc. | 2.08% | 312.83 | 3.5% | $317.70m | |
| REGN | Regeneron Pharmaceuticals, Inc. | 3.27% | 320.09 | 2.6% | $298.61m | |
| A | Agilent Technologies, Inc. | -0.50% | 67.98 | 1.6% | $207.68m | |
| VRTX | Vertex Pharmaceuticals Incorporated | 1.92% | 172.37 | 1.9% | $181.17m | |
| EXAS | Exact Sciences Corporation | -2.10% | 94.91 | 25.3% | $163.66m | |
| ALXN | Alexion Pharmaceuticals, Inc. | -0.97% | 127.55 | 2.0% | $149.64m | |
| BMRN | BioMarin Pharmaceutical Inc. | 0.25% | 87.69 | 4.3% | $118.55m | |
| SRPT | Sarepta Therapeutics, Inc. | 0.36% | 121.62 | 14.7% | $112.14m | |
| INCY | Incyte Corporation | 0.43% | 79.02 | 2.5% | $105.72m | |
| IONS | Ionis Pharmaceuticals, Inc. | -0.98% | 68.56 | 8.2% | $98.74m | |
| ALNY | Alnylam Pharmaceuticals, Inc | -0.09% | 67.81 | 9.2% | $94.94m |
Company Profile
Selecta Biosciences, Inc. operates as a clinical-stage biopharmaceutical company, which engages in the research and development of nanoparticle immunomodulatory drugs for the treatment and prevention of human diseases. it produces the Synthetic Vaccine Particles (SVP) platform for immune tolerance and immune stimulation. The firm proprietary pipeline includes SVP-enabled enzyme, oncology and gene therapies. The company was founded by Omid C. Farokhzad, Robert S. Langer Jr., and Ulrich von Andrian in 2007 and is headquartered in Watertown, MA.